Harvard Bioscience (HBIO) Asset Writedowns and Impairment (2010 - 2020)
Harvard Bioscience's (HBIO) quarterly Asset Writedowns and Impairment came in at $763000.0 in Q4 2020, up 819.81% year-on-year from $82951.8 in Q1 2020, and up 18975.0% on a QoQ basis from $4000.0 in Q1 2020.
Harvard Bioscience (HBIO) Asset Writedowns and Impairment (2010 - 2020) Analysis & Trends
Harvard Bioscience (HBIO) has 11 years of Asset Writedowns and Impairment data on file, last reported at $763000.0 in Q4 2020.
- On a quarterly basis, Asset Writedowns and Impairment rose 819.81% year-over-year to $763000.0 in Q4 2020; TTM through Dec 2020 was $767000.0, a 53.32% decrease from a year earlier, with the FY2020 full-year figure at $787000.0, up 173.26% from the prior year.
- Asset Writedowns and Impairment for Q4 2020 stood at $763000.0, up from $4000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for HBIO reached as high as $941000.0 in Q2 2019 and fell as low as -$411000.0 in Q4 2016.
- Historically, Asset Writedowns and Impairment has averaged $176800.0 across 5 years, with a median of $22000.0 in 2018.
- Across the five-year window, Asset Writedowns and Impairment sank 13600.0% in 2016 and surged 6860.0% in 2019, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at -$411000.0 in 2016, then surged by 73.24% to -$110000.0 in 2017, then soared by 120.0% to $22000.0 in 2018, then plunged by 581.82% to -$106000.0 in 2019, then soared by 819.81% to $763000.0 in 2020.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $763000.0 in Q4 2020, $4000.0 in Q1 2020, and -$106000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.22 Bn | 121.00 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.93 Bn | 44.11 Bn | 2.15 Bn |
| 3 | Alcon | 33.19 Bn | 31.53 Bn | 1.53 Bn |
| 4 | Medline | 33.03 Bn | 30.80 Bn | 1.84 Bn |
| 5 | Resmed | 29.47 Bn | 27.81 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.58 Bn | 23.15 Bn | 329.20 Mn |
| 7 | Solventum | 14.03 Bn | 13.47 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.92 Bn | 13.78 Bn | 735.40 Mn |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn |
| 10 | Harvard Bioscience | 27.26 Mn | 20.16 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 763,000.00 |
| Dec 31, 2020 | 763,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | -106,000.00 |
| Dec 31, 2019 | -106,000.00 |
| Sep 30, 2019 | 460,000.00 |
| Sep 30, 2019 | 460,000.00 |
| Jun 30, 2019 | 941,000.00 |
| Jun 30, 2019 | 941,000.00 |
| Mar 31, 2019 | 348,000.00 |
| Mar 31, 2019 | 348,000.00 |
| Dec 31, 2018 | 22,000.00 |
| Dec 31, 2018 | 22,000.00 |
| Mar 31, 2018 | 5,000.00 |
| Mar 31, 2018 | 5,000.00 |
| Dec 31, 2017 | -110,000.00 |
| Dec 31, 2017 | -110,000.00 |
| Jun 30, 2017 | 31,000.00 |
| Jun 30, 2017 | 31,000.00 |